TVRD
Tvardi Therapeutics
TVRD
TVRD
167 hedge funds and large institutions have $703M invested in Tvardi Therapeutics in 2021 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 44 increasing their positions, 48 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 155 → 167 (+12)
0.02% less ownership
Funds ownership: 1.82% → 1.8% (-0.02%)
8% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 48
Holders
167
Holding in Top 10
3
Calls
$52.7M
Puts
$20.5M
Top Buyers
| 1 | +$6.19M | |
| 2 | +$5.22M | |
| 3 | +$4.29M | |
| 4 |
Two Sigma Investments
New York
|
+$4.02M |
| 5 |
BCM
Burrage Capital Management
Boston,
Massachusetts
|
+$3.91M |
Top Sellers
| 1 | -$13M | |
| 2 | -$10.6M | |
| 3 | -$6.57M | |
| 4 |
RCP
Rho Capital Partners
New York
|
-$5.43M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$4.21M |